Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EbolaCov
NCT06587503Phase 4Not yet recruiting
- Sponsor
- University of Birmingham
- Start
- Oct 2024
- Primary completion
- Dec 2024
- Modality
- Viral Vector Vaccines
01
Overview
A Phase 4 trial of Ebola Zaire vaccine (live, attenuated) in Ebola virus disease (EVD), sponsored by University of Birmingham. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
Ebola Zaire vaccine (live, attenuated)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on NCT06587503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06587503.